A

Arena Pharmaceuticals Inc
F:RN3N

Watchlist Manager
Arena Pharmaceuticals Inc
F:RN3N
Watchlist
Price: 90.5 EUR 0.56%
Market Cap: 5.6B EUR

Cash Flow Statement

Cash Flow Statement
Arena Pharmaceuticals Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Mar-2012 Jun-2012 Sep-2012 Dec-2012 Mar-2013 Jun-2013 Sep-2013 Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021
Operating Cash Flow
Net Income
(96)
(95)
(88)
(86)
(78)
(16)
(17)
(19)
(26)
(58)
(52)
(61)
(60)
(94)
(110)
(108)
(105)
(106)
(92)
(23)
(24)
(20)
(41)
(93)
(102)
(110)
(112)
(29)
623
593
555
398
(323)
(346)
(371)
(405)
(423)
(484)
(583)
(616)
Depreciation & Amortization
11
10
10
10
9
9
8
8
8
9
9
9
9
10
10
10
10
10
10
5
4
4
3
4
4
3
3
4
4
4
3
3
3
4
4
4
4
4
4
4
Change in Deffered Taxes
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(110)
0
0
0
110
0
0
0
0
0
0
0
0
Other Non-Cash Items
14
35
30
26
18
(5)
(3)
(1)
4
(27)
(40)
(40)
(38)
(4)
15
15
12
14
13
33
28
30
40
14
20
18
6
14
22
29
38
51
55
56
57
49
38
45
120
131
Cash Interest Paid
0
0
0
8
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
1
2
3
4
Change in Working Capital
(5)
(20)
(3)
5
11
28
30
85
85
71
50
(10)
(17)
(7)
(11)
(15)
(10)
(3)
(9)
(77)
(68)
(83)
(72)
8
(2)
(2)
(1)
(10)
(13)
(8)
0
6
2
2
2
(1)
2
41
21
30
Cash from Operating Activities
(76)
N/A
(69)
+10%
(51)
+26%
(44)
+13%
(40)
+9%
16
N/A
18
+14%
73
+298%
72
-1%
(6)
N/A
(34)
-488%
(101)
-203%
(105)
-4%
(95)
+9%
(96)
0%
(98)
-3%
(93)
+6%
(85)
+8%
(78)
+8%
(62)
+22%
(60)
+2%
(70)
-16%
(69)
+2%
(67)
+3%
(80)
-20%
(92)
-15%
(105)
-14%
(132)
-26%
635
N/A
618
-3%
596
-3%
569
-5%
(263)
N/A
(286)
-9%
(308)
-8%
(353)
-15%
(379)
-7%
(395)
-4%
(438)
-11%
(452)
-3%
Investing Cash Flow
Capital Expenditures
(1)
(1)
(1)
(2)
(3)
(4)
(5)
(9)
(10)
(10)
(11)
(9)
(8)
(6)
(13)
(11)
(10)
(10)
(1)
(1)
(1)
(1)
(0)
(0)
(0)
(1)
(1)
(1)
(2)
(2)
(3)
(5)
(4)
(4)
(3)
(1)
(0)
(1)
(71)
(71)
Other Items
0
(0)
(0)
(0)
(1)
(0)
0
1
1
34
50
50
50
16
2
3
3
3
1
0
0
0
1
(112)
(110)
(88)
(50)
(251)
(427)
(924)
(942)
(492)
(279)
311
262
(21)
167
216
296
392
Cash from Investing Activities
(1)
N/A
(1)
-38%
(2)
-64%
(2)
-22%
(3)
-50%
(5)
-36%
(5)
-9%
(9)
-78%
(10)
-10%
23
N/A
39
+67%
41
+5%
42
+3%
10
-76%
(11)
N/A
(8)
+26%
(7)
+12%
(7)
+8%
(0)
+98%
(1)
-700%
(1)
+13%
(1)
+14%
1
N/A
(112)
N/A
(110)
+2%
(88)
+20%
(51)
+42%
(251)
-394%
(428)
-70%
(927)
-116%
(945)
-2%
(497)
+47%
(284)
+43%
307
N/A
260
-15%
(21)
N/A
167
N/A
215
+29%
226
+5%
321
+42%
Financing Cash Flow
Net Issuance of Common Stock
58
144
167
168
111
26
3
3
6
6
6
5
104
104
103
104
2
1
1
0
6
82
248
249
629
554
389
389
7
10
13
13
13
333
341
354
459
148
143
140
Net Issuance of Debt
(14)
(27)
(27)
(24)
(19)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(3)
(3)
(3)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
Other
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
44
N/A
117
+164%
140
+19%
144
+3%
92
-36%
24
-74%
2
-93%
2
N/A
4
+141%
4
-7%
4
-5%
3
-11%
102
+3 091%
101
-1%
101
0%
101
+0%
(1)
N/A
(2)
-78%
(2)
-19%
(2)
-21%
3
N/A
79
+2 711%
245
+212%
245
N/A
625
+155%
551
-12%
385
-30%
385
N/A
3
-99%
7
+97%
10
+52%
10
N/A
10
-3%
329
+3 328%
338
+3%
351
+4%
455
+30%
144
-68%
139
-4%
135
-2%
Change in Cash
Effect of Foreign Exchange Rates
1
(1)
0
1
(0)
(1)
(0)
0
1
1
(1)
(1)
(1)
(0)
(1)
(2)
(1)
(2)
1
(0)
(1)
1
0
2
2
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
Net Change in Cash
(32)
N/A
46
N/A
88
+90%
99
+12%
48
-51%
35
-27%
15
-57%
66
+339%
67
+2%
22
-67%
8
-65%
(59)
N/A
38
N/A
16
-58%
(7)
N/A
(7)
-1%
(102)
-1 330%
(95)
+7%
(80)
+16%
(65)
+19%
(59)
+8%
9
N/A
178
+1 811%
68
-62%
437
+540%
371
-15%
230
-38%
2
-99%
211
+9 477%
(302)
N/A
(338)
-12%
82
N/A
(537)
N/A
351
N/A
289
-17%
(24)
N/A
243
N/A
(36)
N/A
(73)
-104%
5
N/A
Free Cash Flow
Free Cash Flow
(77)
N/A
(70)
+9%
(52)
+25%
(46)
+12%
(43)
+7%
12
N/A
13
+11%
64
+393%
62
-3%
(16)
N/A
(45)
-176%
(110)
-148%
(113)
-2%
(102)
+10%
(109)
-7%
(109)
0%
(103)
+6%
(95)
+8%
(79)
+16%
(62)
+21%
(61)
+2%
(70)
-16%
(69)
+2%
(67)
+3%
(81)
-21%
(92)
-15%
(105)
-14%
(133)
-26%
634
N/A
616
-3%
593
-4%
564
-5%
(267)
N/A
(289)
-8%
(311)
-7%
(354)
-14%
(380)
-7%
(396)
-4%
(508)
-29%
(523)
-3%